已发表论文

药物递送纳米系统治疗脓毒症的潜力

 

Authors Shi Y, Zhu ML, Wu Q, Huang Y, Xu XL, Chen W

Received 17 September 2021

Accepted for publication 8 December 2021

Published 19 December 2021 Volume 2021:14 Pages 7065—7077

DOI https://doi.org/10.2147/JIR.S339113

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Professor Ning Quan

Abstract: Sepsis is a major immune response disorder caused by infection, with very high incidence and mortality rates. In the clinic, sepsis and its complications are mainly controlled and treated with antibiotics, anti-inflammatory, and antioxidant drugs. However, these treatments have some shortcomings, such as rapid metabolism and severe side effects. The emergence of drug delivery nanosystems can significantly improve tissue permeability, prolong drugs’ circulation time, and reduce side effects. In this paper, we reviewed recent drug delivery nanosystems designed for sepsis treatment based on their mechanisms (anti-bacterial, anti-inflammatory, and antioxidant). Although great progress has been made recently, clinical practice transformation is still very difficult. Therefore, we also discussed key obstacles, including tissue distribution, overcoming bacterial resistance, and single treatment modes. Finally, a rigorous optimization of drug delivery nanosystems is expected to present great potential for sepsis therapy.
Keywords: sepsis, anti-bacterial, anti-inflammatory, anti-oxidative, drug delivery nanosystems, multidrug resistance